2022 Q1 Form 10-Q Financial Statement

#000164033422000354 Filed on February 18, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $53.71K $38.27K $0.00
YoY Change 4490.6%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $53.71K $38.27K $0.00
YoY Change 4490.6% -98.39%
Operating Profit -$53.71K -$38.27K
YoY Change -98.39%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$53.71K -$38.27K $0.00
YoY Change 4490.6% -98.39%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$53.71K -$38.27K $0.00
YoY Change 4490.6% -98.39%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.02
Diluted Earnings Per Share -$33.10K -$23.59K $0.00
COMMON SHARES
Basic Shares Outstanding 162.3M shares 1.623M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.190K
YoY Change
Accrued Expenses $26.65K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $91.98K $38.27K
YoY Change 228.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $91.98K $38.27K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $91.98K $38.27K
YoY Change 228.73%
SHAREHOLDERS EQUITY
Retained Earnings -$2.575M -$2.536M
YoY Change
Common Stock $2.535M $2.535M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$91.98K -$38.27K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$53.71K -$38.27K $0.00
YoY Change 4490.6% -98.39%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$29.26K -$36.07K $0.00
YoY Change 451.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 29.26K $36.07K 0.000
YoY Change 451.04% 770.93%
NET CHANGE
Cash From Operating Activities -29.26K -36.07K 0.000
Cash From Investing Activities
Cash From Financing Activities 29.26K $36.07K 0.000
Net Change In Cash 0.000 $36.07K 0.000
YoY Change 770.93%
FREE CASH FLOW
Cash From Operating Activities -$29.26K -$36.07K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
162255000 shares
CY2021Q4 us-gaap Cash
Cash
0 USD
CY2021Q3 us-gaap Cash
Cash
0 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q4 us-gaap Assets
Assets
0 USD
CY2021Q3 us-gaap Assets
Assets
0 USD
CY2021Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
2191 USD
CY2021Q3 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
0 USD
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
36074 USD
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
38265 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
0 USD
CY2021Q4 us-gaap Liabilities
Liabilities
38265 USD
CY2021Q3 us-gaap Liabilities
Liabilities
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
16226 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
16226 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2519102 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2519102 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2574593 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2536328 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-38265 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q4 us-gaap Revenues
Revenues
0 USD
CY2020Q4 us-gaap Revenues
Revenues
0 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
734 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
300 USD
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
37531 USD
CY2020Q4 us-gaap Professional Fees
ProfessionalFees
3843 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2369070 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
38265 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
2373213 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-38265 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2373213 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38265 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2373213 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-38265 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-2373213 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021Q4 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
162255000 shares
CY2020Q4 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
161637609 shares
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38265 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-38265 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-22669 USD
CY2020Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2369070 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2373213 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-26812 USD
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38265 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2373213 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2369070 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2191 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
CY2021Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-36074 USD
CY2020Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-4142 USD
CY2021Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
36074 USD
CY2020Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4142 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36074 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4142 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q4 pglo Working Capital
WorkingCapital
38265 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2574593 USD
CY2021Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>

Files In Submission

Name View Source Status
0001640334-22-000354-index-headers.html Edgar Link pending
0001640334-22-000354-index.html Edgar Link pending
0001640334-22-000354.txt Edgar Link pending
0001640334-22-000354-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pan_10q.htm Edgar Link pending
pan_10q_htm.xml Edgar Link completed
pan_ex311.htm Edgar Link pending
pan_ex321.htm Edgar Link pending
pglo-20211231.xsd Edgar Link pending
pglo-20211231_cal.xml Edgar Link unprocessable
pglo-20211231_def.xml Edgar Link unprocessable
pglo-20211231_lab.xml Edgar Link unprocessable
pglo-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending